Eurasian – American Innovation Technology Week Seminar Sessions at the Hermes Expo

Globalization of clinical trials is the result of the U.S. Pharma business actively entering international markets, demand for higher patient population size, ICH-GCP principles implementation worldwide, cost effectiveness, and many other reasons. Among all the regions, emerging markets such as China, Brazil, India, Asia Pacific, Russia and Eastern Europe became very popular to place clinical studies.

Last week Nataliya Katsnelson, GCT Senior Business Development Manager presented on the topic of acceptance of the data from foreign investigations by the U.S. FDA during 22nd Annual Eurasian – American Innovation Technology Week (RANIT) Seminar Sessions at the Hermes Expo.

GCT would like to thank the organizer of series regional industry events, the Mid-Atlantic – Eurasia Business Council President Val Kogan

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.